We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
Decentralized trials have become a prominent trend in the sphere of clinical research. Recent advancements in AI and overall digitalization have further accelerated the process of decentralization. Join us for an insightful interview with Craig Lipset, a leading figure in digital R&D innovations in the life science industry, CEO & Founder of Clinical Innovation Partners. Explore the current state of decentralized trials, the role of AI and wearables, overcoming barriers to universal adoption, FDA's perspective, patient enrollment and many other related topics in our new Industry Voice video podcast episode.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
